Previous
Previous
Vaccine Access in the U.S. – Fall 2025 Update
Next
Next
Vaccine safety evaluation continues long after approval through post-marketing surveillance systems that analyze real-world data from millions of people. Learn how monitoring tools like VAERS and the Vaccine Safety Datalink help identify rare side effects, strengthen transparency, and ensure ongoing vaccine safety.
Recently, shifts in federal vaccine advisory processes in the United States have sparked discussion across the healthcare landscape. In response, organizations such as the Massachusetts Medical Society and the Vaccine Integrity Project have announced plans to conduct independent evidence reviews of influenza, COVID-19, and RSV vaccines.
After years of flu, COVID-19, and RSV vaccine campaigns, many people are experiencing “vaccine fatigue.” This post explores why engagement is declining across workplaces and college campuses and how empathy, education, and convenience can help rebuild trust and participation.